HERTFORDSHIRE, England and PITTSBURGH, Dec. 11, 2017 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today announced that Teva has dismissed its pending district court litigation against Mylan regarding Mylan’s Glatiramer Acetate Injection 40 mg/mL, the first generic version of Copaxo…